This year, 6 brokers from across the brokerage field were named as the 2023 M&A Power Broker winners. An additional five brokers were named as finalists.
Digital transformation, clinical trials, climate change and product recalls are among the top risks and opportunities facing the life sciences sector over the next several years.
This year, six brokers from across the brokerage field were named as the 2022 M&A Power Broker winners. An additional four brokers were named as finalists.
Alliant’s Emily Quinlan has taken her time to best understand the industry so that her clients get top information with little confusion and plenty of assurance.